Icar Prenatal Essential Omega-3 Interactions
There are 72 drugs known to interact with Icar Prenatal Essential Omega-3 (omega-3 polyunsaturated fatty acids), along with 2 disease interactions. Of the total drug interactions, 72 are moderate.
- View all 72 medications that may interact with Icar Prenatal Essential Omega-3
- View Icar Prenatal Essential Omega-3 disease interactions (2)
Most frequently checked interactions
View interaction reports for Icar Prenatal Essential Omega-3 (omega-3 polyunsaturated fatty acids) and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Alpha-Lipoic-Acid-300 (alpha-lipoic acid)
- atenolol
- Atrovent Nasal (ipratropium nasal)
- Azurette (desogestrel / ethinyl estradiol)
- banaba
- beta glycans
- biotin
- bitter melon
- boron
- bupropion
- calcium carbonate
- Catapres (clonidine)
- chromium picolinate
- cinnamon
- Clarinex (desloratadine)
- Claritin (loratadine)
- copper gluconate
- cranberry
- Cylert (pemoline)
- Desoxyn (methamphetamine)
- Dexedrine (dextroamphetamine)
- Dextrostat (dextroamphetamine)
- Diflucan (fluconazole)
- Flexeril (cyclobenzaprine)
- Flonase (fluticasone nasal)
- fluocinolone otic
- metformin
- Vitamin B12 (cyanocobalamin)
Icar Prenatal Essential Omega-3 disease interactions
There are 2 disease interactions with Icar Prenatal Essential Omega-3 (omega-3 polyunsaturated fatty acids) which include:
More about Icar Prenatal Essential Omega-3 (omega-3 polyunsaturated fatty acids)
- Icar Prenatal Essential Omega-3 consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: nutraceutical products
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.